Allopurinol
Rank #234 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$56.9M
Total Cost
3,852,206
Total Claims
$56.9M
Total Cost
78,466
Prescribers
$15
Cost per Claim
850,618
Beneficiaries
9,160,297
30-Day Fills
$725
Avg Cost/Provider
49
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$56.9M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $56.9M total
🔎 Data Overview
At $15.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Allopurinol
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Ashar Luqman | Nephrology | Sioux City, IA | 4,226 | $35K |
| 2 | Ajith Kuriakose | Nephrology | Beaumont, TX | 1,616 | $20K |
| 3 | Lisa Weber | Nephrology | Wichita, KS | 1,253 | $20K |
| 4 | Usman Khan | Nephrology | Ottawa, IL | 853 | $15K |
| 5 | Sharon Fey | Physician Assistant | Sioux City, IA | 1,443 | $13K |
| 6 | Paula Henderson | Family Practice | Hemet, CA | 674 | $13K |
| 7 | Mark Song | Internal Medicine | Los Angeles, CA | 547 | $13K |
| 8 | Michael Satchell | Family Practice | Albany, GA | 1,735 | $13K |
| 9 | Kyaw Moe | Nephrology | Lakewood, CA | 899 | $12K |
| 10 | Timothy Estes | Family Practice | Jackson, MS | 1,372 | $12K |
| 11 | Joseph Grisanti | Rheumatology | Orchard Park, NY | 462 | $12K |
| 12 | Chang Lee | Internal Medicine | Flushing, NY | 1,232 | $12K |
| 13 | Hung Dang | Family Practice | Arlington, TX | 308 | $11K |
| 14 | Rajesh Agarwal | Internal Medicine | Mayfield Heights, OH | 858 | $11K |
| 15 | Quynh Lam | Nephrology | Houston, TX | 649 | $11K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 231 | Somatropin (Genotropin) | $57.4M | 8,552 |
| 232 | Lumateperone Tosylate (Caplyta) | $57.4M | 35,791 |
| 233 | Everolimus (Everolimus) | $57.0M | 8,962 |
| 234 | Allopurinol (Allopurinol) | $56.9M | 3,852,206 |
| 235 | Exenatide Microspheres (Bydureon Bcise) | $56.6M | 48,670 |
| 236 | Valsartan (Valsartan) | $56.4M | 1,481,937 |
| 237 | Benralizumab (Fasenra Pen) | $54.8M | 9,334 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology